|Articles|May 15, 2012

MedPAC Recommendations

In this segment the panel talks about the consequences SGR might have on primary care practices. They discuss what the efficient costs of production are for the healthcare we aim to deliver.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Segment 9 - Impact of Healthcare Reform on Cancer Care

By

November 3rd 2016

Segment 8 - Covering the Gaps in Cancer Survivor Care

By

November 3rd 2016

Segment 7 - Successful Discussions on Advance Care Planning and EOL

By

November 3rd 2016

Segment 6 - Reimbursing Value-Based Oncology Care

By

November 3rd 2016

Segment 5 - An Ideal Patient Portal

By

November 3rd 2016

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

MedPAC Recommendations

Newsletter

Related Content

Segment 9 - Impact of Healthcare Reform on Cancer Care

Segment 8 - Covering the Gaps in Cancer Survivor Care

Segment 7 - Successful Discussions on Advance Care Planning and EOL

Segment 6 - Reimbursing Value-Based Oncology Care

Segment 5 - An Ideal Patient Portal

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”

TrumpRx Launch Brings Savings—and Uncertainty

Exploring Identity, Appearance Experiences Among Patients With Alopecia

5 Things to Know About the Oral GLP-1 Era

Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial